BCA
HUMA icon

Bay Colony Advisors’s Humacyte HUMA Stock Holding History

Bay Colony Advisors’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-14,550
Closed -$79.2K – 468
2024
Q3 		$79.2K Hold
14,550
– – 0.01% 423
2024
Q2 		$69.8K Sell
14,550
-7,900
-35% -$41.1K 0.01% 416
2024
Q1 		$69.8K Buy
22,450
+4,500
+25% +$15.1K 0.01% 401
2023
Q4 		$51K Hold
17,950
– – 0.01% 387
2023
Q3 		$52.6K Buy
+17,950
New +$59.4K 0.01% 339

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bay Colony Advisors's HUMA Position: Q4 2024 in Review

Bay Colony Advisors sold out of Humacyte (HUMA) in Q4 2024, closing a stake of 14,550 shares — an estimated $79.2K sold.

Bay Colony Advisors first reported a position in HUMA in Q3 2023 and held it in 5 quarters. The position peaked at $79.2K in Q3 2024. 162 funds tracked by Wall St. Rank hold HUMA as of Q4 2024.

  • Bay Colony Advisors reported no remaining Humacyte position as of Q4 2024 after selling out during the quarter.
  • Bay Colony Advisors sold 14,550 Humacyte shares in Q4 2024, an estimated $79.2K.
  • Bay Colony Advisors first reported a position in Humacyte in Q3 2023 and held it in 5 quarters.
  • Bay Colony Advisors's Humacyte position peaked at $79.2K in Q3 2024.
  • 162 funds tracked by Wall St. Rank held Humacyte as of Q4 2024.

Based on Bay Colony Advisors's 13F filing for Q4 2024, filed 7 Feb 2025.